CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo

Clinical OMICsHormone Cell Atlas Maps Body’s Chemical Messengers

Clinical OMICsSHIMMER: Routine Clinical Data Processed Into Scalable Disease State Markers

Endpoints NewsLilly obesity meds Foundayo and Zepbound to gain CVS coverage

Eli LillyEli Lilly Stock Heads for Record Close. CVS Weight-Loss Drug Coverage Drives It Higher. - Barron's

IlluminaIllumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research - PR Newswire

Thermo FisherThermo Fisher Launches E-Gel Power Snap Lite System - Contract Pharma

BioPharma DiveGSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’

BioWorldAppointments and advancements for May 28, 2026

BioWorldFinancings for May 28, 2026

BioWorldIn the clinic for May 28, 2026

BioWorldOther news to note for May 28, 2026

BioWorldRegulatory actions for May 28, 2026